Global Swine Healthcare 麻豆原创 Research Report 2023

Publication ID:

PB502234487

Publication Date:

February 7, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Swine health is associated with the diseases caused due to pigs and the development of therapeutics to prevent the related ailments and disorders. Pig breeding can lead to many diseases such as reproductive disease and congenital malformations. Hence, governmental organizations are launching programs to protect and enhance the health of swine, which reduces the effect of swine diseases on humans.
Highlights
The global Swine Healthcare market was valued at US$ 2020.6 million in 2022 and is anticipated to reach US$ 2631.3 million by 2029, witnessing a CAGR of 4.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The increasing demand for livestock products on a global level will drive the growth prospects for the global swine health market during the predicted period. The adoption rate of antibiotics, vaccines, and other treatments is anticipated to grow with the increasing number of initiatives taken by government and vendors to prevent any zoonotic disease from affecting livestock production. Since the production of quality livestock products is dependent on the health of the animal, many vendors are increasingly adopting more number of drugs to prevent and treat diseases of swine. The above two factors will boost the demand for drugs, antibiotics, and vaccines, which, in turn, will propel the rate of revenue generation in the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swine Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Healthcare.
The Swine Healthcare market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Swine Healthcare market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Zoetis
Merck
Elanco (Eli Lilly)
Boehringer Ingelheim
Ceva Sante Animale
Vetoquinol
Segment by Type
Vaccines
Parasiticides
Anti-Infectives
Medicinal Feed Additives
Others
Segment by Application
Farm
House
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Swine Healthcare companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Swine Healthcare 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Vaccines
1.2.3 Parasiticides
1.2.4 Anti-Infectives
1.2.5 Medicinal Feed Additives
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global Swine Healthcare 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Farm
1.3.3 House
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Swine Healthcare 麻豆原创 Perspective (2018-2029)
2.2 Swine Healthcare Growth Trends by Region
2.2.1 Global Swine Healthcare 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Swine Healthcare Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Swine Healthcare Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Swine Healthcare 麻豆原创 Dynamics
2.3.1 Swine Healthcare Industry Trends
2.3.2 Swine Healthcare 麻豆原创 Drivers
2.3.3 Swine Healthcare 麻豆原创 Challenges
2.3.4 Swine Healthcare 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Swine Healthcare Players by Revenue
3.1.1 Global Top Swine Healthcare Players by Revenue (2018-2023)
3.1.2 Global Swine Healthcare Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Swine Healthcare 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Swine Healthcare Revenue
3.4 Global Swine Healthcare 麻豆原创 Concentration Ratio
3.4.1 Global Swine Healthcare 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Swine Healthcare Revenue in 2022
3.5 Swine Healthcare Key Players Head office and Area Served
3.6 Key Players Swine Healthcare Product Solution and Service
3.7 Date of Enter into Swine Healthcare 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Swine Healthcare Breakdown Data by Type
4.1 Global Swine Healthcare Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Swine Healthcare Forecasted 麻豆原创 Size by Type (2024-2029)
5 Swine Healthcare Breakdown Data by Application
5.1 Global Swine Healthcare Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Swine Healthcare Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Swine Healthcare 麻豆原创 Size (2018-2029)
6.2 North America Swine Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Swine Healthcare 麻豆原创 Size by Country (2018-2023)
6.4 North America Swine Healthcare 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Swine Healthcare 麻豆原创 Size (2018-2029)
7.2 Europe Swine Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Swine Healthcare 麻豆原创 Size by Country (2018-2023)
7.4 Europe Swine Healthcare 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Swine Healthcare 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Swine Healthcare 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Swine Healthcare 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Swine Healthcare 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Swine Healthcare 麻豆原创 Size (2018-2029)
9.2 Latin America Swine Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Swine Healthcare 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Swine Healthcare 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Swine Healthcare 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Swine Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Swine Healthcare 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Swine Healthcare 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Swine Healthcare Introduction
11.1.4 Zoetis Revenue in Swine Healthcare Business (2018-2023)
11.1.5 Zoetis Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Swine Healthcare Introduction
11.2.4 Merck Revenue in Swine Healthcare Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Elanco (Eli Lilly)
11.3.1 Elanco (Eli Lilly) Company Detail
11.3.2 Elanco (Eli Lilly) Business Overview
11.3.3 Elanco (Eli Lilly) Swine Healthcare Introduction
11.3.4 Elanco (Eli Lilly) Revenue in Swine Healthcare Business (2018-2023)
11.3.5 Elanco (Eli Lilly) Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Swine Healthcare Introduction
11.4.4 Boehringer Ingelheim Revenue in Swine Healthcare Business (2018-2023)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Ceva Sante Animale
11.5.1 Ceva Sante Animale Company Detail
11.5.2 Ceva Sante Animale Business Overview
11.5.3 Ceva Sante Animale Swine Healthcare Introduction
11.5.4 Ceva Sante Animale Revenue in Swine Healthcare Business (2018-2023)
11.5.5 Ceva Sante Animale Recent Development
11.6 Vetoquinol
11.6.1 Vetoquinol Company Detail
11.6.2 Vetoquinol Business Overview
11.6.3 Vetoquinol Swine Healthcare Introduction
11.6.4 Vetoquinol Revenue in Swine Healthcare Business (2018-2023)
11.6.5 Vetoquinol Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Zoetis
Merck
Elanco (Eli Lilly)
Boehringer Ingelheim
Ceva Sante Animale
Vetoquinol

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.